VYNE icon

VYNE Therapeutics
VYNE

Overview Fund Activity

45 hedge funds and large institutions have $13.3M invested in VYNE Therapeutics in 2025 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 7 closing their positions.

Holders
45
Holders Change
+7
Holders Change %
+18.42%
% of All Funds
0.6%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
15
Increased
7
Reduced
12
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
CAM
1
Cormorant Asset Management
Massachusetts
$2.26M
2
KCM
2
Kennedy Capital Management
Missouri
$942K
3
Adage Capital Partners
3
Adage Capital Partners
Massachusetts
$1.06M
4
IC
4
Ikarian Capital
Texas
$479K
5
Jane Street
5
Jane Street
New York
$206K

Top Sellers

1
EAM
1
Eventide Asset Management
Massachusetts
$0
2
EAM
2
Exome Asset Management
New York
$345K
3
PHP
3
Parkman Healthcare Partners
Connecticut
$0
4
Renaissance Technologies
4
Renaissance Technologies
New York
$17.4K
5
PCM
5
Prelude Capital Management
New York
$107K
Name Market Value Shares Shares
Change 		Shares
Change %
SC
51
Shay Capital
New York
– – -18,015 Closed
UBS Group
52
UBS Group
Switzerland
– – -7,576 Closed
1 2
3